Covered recipient · General Payments record
RICHARD P WURTZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,812.75
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.15 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $165.57 | 11 |
| Astellas Pharma US Inc | $119.75 | 4 |
| PFIZER INC. | $17.35 | 1 |
| Acerta Pharma LLC | $15.19 | 1 |
| Abbott Laboratories | $14.93 | 1 |
| Azurity Pharmaceuticals, Inc. | $14.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.93 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125287568 | CMS |
| ABBVIE INC. | $18.92 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365421 | CMS |
| ABBVIE INC. | $5.97 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365423 | CMS |
| ABBVIE INC. | $33.43 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365425 | CMS |
| ABBVIE INC. | $11.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365427 | CMS |
| ABBVIE INC. | $13.22 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365429 | CMS |
| ABBVIE INC. | $16.34 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365431 | CMS |
| ABBVIE INC. | $5.00 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365433 | CMS |
| ABBVIE INC. | $19.87 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365435 | CMS |
| ABBVIE INC. | $17.25 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365437 | CMS |
| ABBVIE INC. | $3.76 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365439 | CMS |
| ABBVIE INC. | $20.24 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106365441 | CMS |
| Astellas Pharma US Inc | $29.09 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139311246 | CMS |
| Astellas Pharma US Inc | $30.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139357153 | CMS |
| Astellas Pharma US Inc | $30.27 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139376214 | CMS |
| Astellas Pharma US Inc | $30.12 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139396809 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.19 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104459246 | CMS |
| Azurity Pharmaceuticals, Inc. | $14.36 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014515 | CMS |
| PFIZER INC. | $17.35 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131840675 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.